Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05773014
Other study ID # 202301012
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 27, 2023
Est. completion date January 1, 2025

Study information

Verified date December 2023
Source Washington University School of Medicine
Contact Julia Burd, MD
Phone (314) 362-7135
Email burd.j@wustl.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

After preterm prelabor rupture of membranes (PPROM)[breaking of the amniotic sac prior to 37 weeks gestation in pregnancy], patients are recommended for inpatient admission and close monitoring for complications including preterm labor, intraamniotic infection (infection of the sac around the baby), and placental abruption (separation of the placenta from wall of the uterus). When evaluation of cervical dilation is clinically indicated, obstetricians traditionally perform sterile speculum exams due to concern for decrease in pregnancy latency (length of time between breaking the water and delivery) with sterile digital exams in retrospective studies. These studies are concerning, however, by the indications for the exams and are at risk for confounding by indication. This is a randomized, non-inferiority trial to examine if sterile digital versus speculum exams effect latency of pregnancy in patients with PPROM.


Recruitment information / eligibility

Status Recruiting
Enrollment 86
Est. completion date January 1, 2025
Est. primary completion date July 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - 22 weeks 0 days gestation to 33 weeks 5 days gestation - Clinical or laboratory confirmation of PPROM - At least 8 hours after rupture event - English speaking Notably, for patients <25 weeks, approach for enrollment will be deferred until after the patient has discussed their desires for fetal resuscitation with the care team and are at a gestational age where they would desire this resuscitation. Exclusion Criteria: - Contraindications to digital examination - COVID-19 positive on admission

Study Design


Related Conditions & MeSH terms

  • Fetal Membranes, Premature Rupture
  • PPROM

Intervention

Procedure:
Speculum Exams
Same as arm
Digital Exams
Same as arm

Locations

Country Name City State
United States Barnes Jewish Hospital Saint Louis Missouri

Sponsors (1)

Lead Sponsor Collaborator
Washington University School of Medicine

Country where clinical trial is conducted

United States, 

References & Publications (4)

Alexander JM, Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Meis PJ, Moawad AH, Iams JD, Vandorsten JP, Paul RH, Dombrowski MP, Roberts JM, McNellis D. The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol. 2000 Oct;183(4):1003-7. doi: 10.1067/mob.2000.106765. — View Citation

Lewis DF, Major CA, Towers CV, Asrat T, Harding JA, Garite TJ. Effects of digital vaginal examinations on latency period in preterm premature rupture of membranes. Obstet Gynecol. 1992 Oct;80(4):630-4. — View Citation

Singhal, S., Puri, M., & Gami, N. (2011). An analysis of factors affecting the duration of latency period and its impact on neonatal outcome in patients with PPROM. International Journal of Infertility and Fetal Medicine. 2012; 3(3): 87-91.

Sukcharoen N, Vasuratna A. Effects of digital cervical examinations on duration of latency period, maternal and neonatal outcome in preterm premature rupture of membranes. J Med Assoc Thai. 1993 Apr;76(4):203-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pregnancy latency time from admission to delivery up to 10 weeks
Secondary Maternal chorioamnionitis Per criteria of American College of Obstetricians and Gynecologists (ACOG): includes fever greater than or equal to 100.4 degrees Farenheit plus an additional sign such as fundal tenderness, white blood cell count >15, purulent vaginal discharge, fetal tachycardia, or placental culture with finding of chorioamnionitis. Suspected chorioamnionitis can also be diagnosed with isolated fever >102.2 degrees Fahrenheit Prior to delivery
Secondary Endomyometritis Clinical diagnosis of uterine infection after delivery, typically with fever and fundal tenderness Within 2 weeks of delivery
Secondary Maternal sepsis Defined as bacteremia with evidence of organ dysfunction Within 2 weeks of delivery
Secondary Maternal wound infections As diagnosed by the clinicians Within 2 weeks of delivery
Secondary Maternal intensive care unit (ICU) admission transfer to ICU or readmission to ICU Within 2 weeks of delivery
Secondary Maternal death Death of mother Within 2 weeks postpartum
Secondary Composite neonatal morbidity Need for respiratory support, neonatal sepsis, intraventricular hemorrhage, hypoxic ischemic encephalopathy, necrotizing enterocolitis, pneumonia, or neonatal demise 28 days of life
Secondary Length of neonatal intensive care unit (NICU) admission From delivery until discharge from the NICU Up to 1 year
Secondary Need for respiratory support One or more of the following: Continuous positive airway pressure (CPAP) or high-flow nasal cannula for at least 2 consecutive hours, supplemental oxygen with a fraction of inspired oxygen of at least 0.30 for at least 4 continuous hours, extracorporeal membrane oxygenation (ECMO), or mechanical ventilation 28 days of life
Secondary Neonatal sepsis at <72 hours of life must be confirmed on blood culture Within 72 hours of birth
Secondary Neonatal sepsis at >72 hours of life must be confirmed on blood culture 28 days of life
Secondary Neonatal intraventricular hemorrhage (IVH) Seen on head ultrasound 28 days of life
Secondary Necrotizing enterocolitis (NEC) As diagnosed by NICU team 28 days of life
Secondary Hypoxic ischemic encephalopathy As diagnosed by NICU team 28 days of life
Secondary Neonatal pneumonia As diagnosed by NICU team 28 days of life
Secondary Neonatal death As documented in the EMR During NICU admission, up to 1 year
Secondary Patient satisfaction with exams Survey regarding their experience with cervical exams At delivery
See also
  Status Clinical Trial Phase
Terminated NCT02939742 - Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity? Phase 2/Phase 3
Recruiting NCT05322252 - Simultaneous Mifepristone and Misoprostol Versus Misoprostol Alone for Induction of Labor of Nonviable Second Trimester Pregnancy: a Pilot Randomized Controlled Trial Phase 4
Not yet recruiting NCT02069587 - Pomegranate to Reduce Maternal and Fetal Oxidative Stress and to Improve Outcome in Pregnancies Complicated With Preterm Premature Rupture of Membranes N/A
Recruiting NCT06443788 - Trans-perineal Ultrasound in Assessment of PPROMs N/A
Recruiting NCT03819192 - Predicting EONS in PPROM Patients
Not yet recruiting NCT03739463 - Pro-omega-3, Reduction of Inflammation and Modulation of Prematurity N/A